Antibodies
21 July 2007
Avastin receives positive opinion in Europe for first-line treatment of patients with advanced lung cancer19 July 2007
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome13 July 2007
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer13 July 2007
Phase II Study of IMC-A12 for Advanced Colorectal Cancer Has Commenced Patient Enrollment11 July 2007
Peregrine Pharmaceuticals Initiates Bavituximab Clinical Trial in HCV Patients Co-Infected With HIV3 July 2007
Ablynx announces interim results of first nanobody (R) phase i study of ALX-0081 (anti-vWF)30 June 2007
Genmab regains rights to HuMax-CD430 June 2007
WILEX to follow FDA advice and apply for a special protocol assessment (SPA) for CA9-SCAN23 June 2007
Alexion’s Soliris(TM) granted marketing approval in europe for treatment of all patients with PNH19 June 2007
Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including OncologyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports